Stay updated with breaking news from Cardio Suite. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Concert AI's TeraRecon, the advanced visualization and clinical AI SaaS company, announced today that its Eureka Clinical AI platform's Cardio...
Last week, the FDA authorized marketing for Viz.AI’s Viz HCM, a standalone ECG analysis software to identify adult patients for further follow-up for hypertrophic cardiomyopathy.
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and triage patients suspected with HCM Viz.ai, a leader in AI-powered disease detection